These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 27043121)
1. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121 [TBL] [Abstract][Full Text] [Related]
2. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214 [TBL] [Abstract][Full Text] [Related]
3. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Marks KR; Lile JA; Stoops WW; Rush CR Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531 [TBL] [Abstract][Full Text] [Related]
4. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Stoops WW; Pike E; Hays LR; Glaser PE; Rush CR Pharmacol Biochem Behav; 2015 Feb; 129():45-50. PubMed ID: 25459104 [TBL] [Abstract][Full Text] [Related]
5. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501 [TBL] [Abstract][Full Text] [Related]
7. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans. Stoops WW; Bennett JA; Lile JA; Sevak RJ; Rush CR Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():111-7. PubMed ID: 23994622 [TBL] [Abstract][Full Text] [Related]
8. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556 [TBL] [Abstract][Full Text] [Related]
9. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503 [TBL] [Abstract][Full Text] [Related]
10. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Stoops WW; Lile JA; Robbins CG; Martin CA; Rush CR; Kelly TH Addict Behav; 2007 Jun; 32(6):1177-88. PubMed ID: 17011712 [TBL] [Abstract][Full Text] [Related]
11. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder. Mooney LJ; Hillhouse MP; Thomas C; Ang A; Sharma G; Terry G; Chang L; Walker R; Trivedi M; Croteau D; Sparenborg S; Ling W J Addict Med; 2016; 10(4):236-43. PubMed ID: 27379819 [TBL] [Abstract][Full Text] [Related]